ZA200705935B - Arabinose- and xylose-fermenting saccharomyces cerevisiae strains - Google Patents
Arabinose- and xylose-fermenting saccharomyces cerevisiae strains Download PDFInfo
- Publication number
- ZA200705935B ZA200705935B ZA200705935A ZA200705935A ZA200705935B ZA 200705935 B ZA200705935 B ZA 200705935B ZA 200705935 A ZA200705935 A ZA 200705935A ZA 200705935 A ZA200705935 A ZA 200705935A ZA 200705935 B ZA200705935 B ZA 200705935B
- Authority
- ZA
- South Africa
- Prior art keywords
- xylose
- arabinose
- strain
- genes
- cerevisiae
- Prior art date
Links
- 240000004808 Saccharomyces cerevisiae Species 0.000 title description 14
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 title description 14
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 claims description 66
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 claims description 63
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 claims description 54
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 claims description 36
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 22
- 108090000623 proteins and genes Proteins 0.000 claims description 22
- 230000037361 pathway Effects 0.000 claims description 19
- 102000016912 Aldehyde Reductase Human genes 0.000 claims description 13
- 108010053754 Aldehyde reductase Proteins 0.000 claims description 13
- 108010058076 D-xylulose reductase Proteins 0.000 claims description 13
- 102100026974 Sorbitol dehydrogenase Human genes 0.000 claims description 13
- 108700040099 Xylose isomerases Proteins 0.000 claims description 13
- 108010018080 L-arabinose isomerase Proteins 0.000 claims description 10
- 230000002018 overexpression Effects 0.000 claims description 10
- 230000003827 upregulation Effects 0.000 claims description 10
- 235000014469 Bacillus subtilis Nutrition 0.000 claims description 7
- 108091022915 xylulokinase Proteins 0.000 claims description 7
- 241000588724 Escherichia coli Species 0.000 claims description 6
- 102100029089 Xylulose kinase Human genes 0.000 claims description 6
- 241000235060 Scheffersomyces stipitis Species 0.000 claims description 5
- 101150035354 araA gene Proteins 0.000 claims description 5
- 230000008021 deposition Effects 0.000 claims description 4
- ZAQJHHRNXZUBTE-WUJLRWPWSA-N D-xylulose Chemical compound OC[C@@H](O)[C@H](O)C(=O)CO ZAQJHHRNXZUBTE-WUJLRWPWSA-N 0.000 claims description 3
- 241000235379 Piromyces Species 0.000 claims description 3
- 241000589499 Thermus thermophilus Species 0.000 claims description 3
- 238000006317 isomerization reaction Methods 0.000 claims description 3
- 108020002667 ribulokinase Proteins 0.000 claims description 3
- 241000588722 Escherichia Species 0.000 claims description 2
- 230000004108 pentose phosphate pathway Effects 0.000 claims description 2
- 241000193830 Bacillus <bacterium> Species 0.000 claims 1
- 239000013612 plasmid Substances 0.000 description 21
- 239000002609 medium Substances 0.000 description 10
- 108020001027 Ribosomal DNA Proteins 0.000 description 8
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 7
- 229910052799 carbon Inorganic materials 0.000 description 7
- 239000012634 fragment Substances 0.000 description 7
- 238000000855 fermentation Methods 0.000 description 6
- 230000004151 fermentation Effects 0.000 description 5
- 239000003550 marker Substances 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- BRZYSWJRSDMWLG-CAXSIQPQSA-N geneticin Chemical compound O1C[C@@](O)(C)[C@H](NC)[C@@H](O)[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](C(C)O)O2)N)[C@@H](N)C[C@H]1N BRZYSWJRSDMWLG-CAXSIQPQSA-N 0.000 description 4
- 239000008103 glucose Substances 0.000 description 4
- 230000010354 integration Effects 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 101150009006 HIS3 gene Proteins 0.000 description 3
- SRBFZHDQGSBBOR-HWQSCIPKSA-N L-arabinopyranose Chemical compound O[C@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-HWQSCIPKSA-N 0.000 description 3
- 101100394989 Rhodopseudomonas palustris (strain ATCC BAA-98 / CGA009) hisI gene Proteins 0.000 description 3
- OIRDTQYFTABQOQ-UHTZMRCNSA-N Vidarabine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O OIRDTQYFTABQOQ-UHTZMRCNSA-N 0.000 description 3
- OIRDTQYFTABQOQ-UHFFFAOYSA-N ara-adenosine Natural products Nc1ncnc2n(cnc12)C1OC(CO)C(O)C1O OIRDTQYFTABQOQ-UHFFFAOYSA-N 0.000 description 3
- 101150017736 araD gene Proteins 0.000 description 3
- 229920001817 Agar Polymers 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- FNZLKVNUWIIPSJ-CRCLSJGQSA-L L-ribulose 5-phosphate(2-) Chemical compound OCC(=O)[C@@H](O)[C@@H](O)COP([O-])([O-])=O FNZLKVNUWIIPSJ-CRCLSJGQSA-L 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 230000014509 gene expression Effects 0.000 description 2
- 150000002402 hexoses Chemical class 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000009630 liquid culture Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000007003 mineral medium Substances 0.000 description 2
- 238000001823 molecular biology technique Methods 0.000 description 2
- 150000002972 pentoses Chemical class 0.000 description 2
- XNGIFLGASWRNHJ-UHFFFAOYSA-L phthalate(2-) Chemical compound [O-]C(=O)C1=CC=CC=C1C([O-])=O XNGIFLGASWRNHJ-UHFFFAOYSA-L 0.000 description 2
- 238000007747 plating Methods 0.000 description 2
- 230000009466 transformation Effects 0.000 description 2
- BRZYSWJRSDMWLG-DJWUNRQOSA-N (2r,3r,4r,5r)-2-[(1s,2s,3r,4s,6r)-4,6-diamino-3-[(2s,3r,4r,5s,6r)-3-amino-4,5-dihydroxy-6-[(1r)-1-hydroxyethyl]oxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol Chemical compound O1C[C@@](O)(C)[C@H](NC)[C@@H](O)[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H]([C@@H](C)O)O2)N)[C@@H](N)C[C@H]1N BRZYSWJRSDMWLG-DJWUNRQOSA-N 0.000 description 1
- 101100272859 Arabidopsis thaliana BXL1 gene Proteins 0.000 description 1
- 101100264262 Aspergillus aculeatus xlnD gene Proteins 0.000 description 1
- 239000002028 Biomass Substances 0.000 description 1
- 241001605679 Colotis Species 0.000 description 1
- 230000005526 G1 to G0 transition Effects 0.000 description 1
- 101100049998 Gibberella zeae (strain ATCC MYA-4620 / CBS 123657 / FGSC 9075 / NRRL 31084 / PH-1) XYLB gene Proteins 0.000 description 1
- 108090000769 Isomerases Proteins 0.000 description 1
- 102000004195 Isomerases Human genes 0.000 description 1
- 108010064700 L-arabinitol 4-dehydrogenase Proteins 0.000 description 1
- 108010080643 L-xylulose reductase Proteins 0.000 description 1
- 102100029137 L-xylulose reductase Human genes 0.000 description 1
- 102100030931 Ladinin-1 Human genes 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 101150100773 XKS1 gene Proteins 0.000 description 1
- 101150095212 XYL2 gene Proteins 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- PYMYPHUHKUWMLA-VAYJURFESA-N aldehydo-L-arabinose Chemical compound OC[C@H](O)[C@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-VAYJURFESA-N 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000013611 chromosomal DNA Substances 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000009510 drug design Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000012737 fresh medium Substances 0.000 description 1
- 239000000446 fuel Substances 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 239000012978 lignocellulosic material Substances 0.000 description 1
- XIXADJRWDQXREU-UHFFFAOYSA-M lithium acetate Chemical compound [Li+].CC([O-])=O XIXADJRWDQXREU-UHFFFAOYSA-M 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- 238000012807 shake-flask culturing Methods 0.000 description 1
- 230000010473 stable expression Effects 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 101150034227 xyl1 gene Proteins 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Description
ARABINOSE- AND XYLOSE-FERMENTING SACCHAROMYCES CEREVISIAE STRAINS
Technical fleid
The present invention relates to a new Saccharomyces cerevisiae strain having an ability to ferment both xylose and arabinose to ethanol.
A substantial fraction of lignocellulosic material consist of pentoses, xylose and arabinose that need to be efficiently converted to make the bioethanol process cost-effective (von
Sivers and Zacchi, 1996). Saccharomyces cerevisiae cannot ferment these pentoses, but it combines high ethanol and inhibitor tolerance and efficient ethanol production from hexoses, which makes it the prime choice of organism for industrial bioethanol production (Hahn-Hagerdal et al., 2001, Adv Biochem Eng Biotechnol, 73:53-84). Stable xylose- fermenting S. cerevisiae strains have been obtained by Integrating the genes from the
Pichia stipitis xylose pathway and overexpressing the endogenous xylulokinase gene (Eliasson et al., 2000, Applied Environ Microbiol, 66:3381-6; Ho et al, 1998, Applied
Environ Microbiol 64:1852-9), however the ethanol yield Is far from theoretical mainly because of a significant production of xylitol. Isomerisation of xylose to xylulose has also been attempted by expressing heterologous xylose isomerase (XI) genes. Functional expression of XI in S. cerevisiae has only been successful with the XI genes from the thermophilic bacterium Thermus thermophilus (Walfridsson et al., 1996, Applied Environ
Microbiol, 62:4648-51) and from the fungus Piromyces spp. (Kuyper et al., 2003, FEMS
Yeast Res 4:69-78). For both pathways, improvement of xylose utilization has notably been achieved via rational design (Jeppsson et ai, 2003, Yeast 20:1263-72 & FEMS Yeast
Res 3:167-75; Johansson and Hahn-Héagerdal, 2002, FEMS Yeast Res 2:277-82;Verho et al, 2003, Applied Environ Microbiol 69:5892-7) and evolutionary engineering (Sonderegger and Sauer, 2003, Applied Environ Microbiol, 69:1990-8; Kuyper et al. 2004, FEMS Yeast
Res 4:655-664).
Summary of the present invention
The present invention relates In particular to S. cerevis/ae strain expressing both arabinose and xylose utilization pathways.
PCT/SE2006/000325
In a preferred embodiment the S. cerevisiae strain ferments both arabinose and xylose to ethanol. .
In a further preferred embodiment the Invention relates to a S. cerevisiae strain with overexpression or upregulation of xylose- or aldose reductase (XR, AR) with xylitol dehydrogenase (XDH) together with overexpression or upregulation of genes forming an arabinose utilization pathway.
In a further preferred embodiment the Invention relates to a S. cerevisiae strain with overexpression or upregulation of xylose isomerase (XI) together with overexpression or upregulation of genes forming an arabinose utilization pathway.
In a further preferred embodiment the invention relates to a S. cerevisiae strain comprising an arabinose utilization pathway consisting of AraA, AraB, AraD, whereby the arabinose utilization pathway is aldose reductase, L-arabinitol 4-dehydrogenase, L-xylulose reductase, D-xyiulose reductase.
In a further preferred embodiment the invention relates to a S. cerevisiae strain with overexpression or upregulation of genes of the pentose phosphate pathway, TKL and/or
TAL and/or RKI and/or RPE.
In a further preferred embodiment the invention relates to a S. cerevisiae strain comprising the genes AraA derived from 8. subtilis, AraB derived from E, coli, AraD derived from E. coli, together with the xylose utilization pathway consisting of xylose reductase (XR) and xylitol dehydrogenase (XDH) from Pichia stipitis and endogenous xylulokinase (XKS) of a S. cerevisiae laboratory strain CEN.PK.
In a further preferred embodiment the Invention relates to a S. cerevisiae strain comprising the genes AraA derived from B. subtilis, AraB derived from E. coli, AraD derived from E. coll, together with the xylose utilization pathway consisting of heterologous xylose
Isomerase (XI) genes for isomerisation of xylose to xylulose comprising the XI genes from the thermophilic bacterium Thermus thermophilus and/or from the fungus Piromyces spp.
In another preferred embodiment the present invention relates to a S. cerevisiae strain
BWY2 deposited under the Budapest convention at the Deutsche Sammlung von
Mikroorganismen und Zellkuituren on February 10, 2005 under the deposition number DSM
In another preferred embodiment the present invention relates to an industrial Ss. cerevisiae strain TMB 3061 deposited under the Budapest convention at the Deutsche
Sammlung von Mikroorganismen und Zellkulturen on April 06, 2005 under the deposition number DSM 17238.
The possibility to introduce an active pathway for arabinose utilization has also recently been demonstrated in a laboratory S. cerevisiae strain (Becker and Boles, 2003). Acquiring a S. cerevisiae strain capable of both xyiose- and arabinose-fermentation, either simultaneously or sequentially, in addition to the naturally occurring hexose fermentation, would increase the economical feasibility of fuel ethanol production from lignocetlulose material. Therefore combining these two capabilities in the same strain is of great commerdal Interest. In this paper, this approach is demonstrated by Introducing the bacterial arabinose utilization pathway consisting of L-arabinose isomerase (AraA) from B. subtilis, a mutant L-ribulokinase (AraB) and L-ribulose-5-p 4-epimerase (AraD), both from
E. coli, together with the xylose utilization pathway consisting of xylose reductase (XR) and xylitol dehydrogenase (XDH) from Pichia stipitis and endogenous xylulokinase (XKS) in a
Ss. cerevisiae laboratory strain CEN.PK. To demonstrate that the method is also applicable to Industrial S. cerevisiae strains, the same arabinose utilization pathway was expressed in the industrial, xylose fermenting strain TMB 3400 (Wahlbom et al. 2003 FEMS Yeast Res 3, 319-26). To achieve stable expression of the exogenous genes, all of them were integrated into the S. cerevisiae genome under the control of a strong promoter. To achieve muitiple integration of genes into the S. cerevisiae genome, a method for integration into the ribosomal DNA sequence was developed.
Materials and methods
Strains and cultivation conditions
Escherichia coll strain DHSa (Life Technologies, Rockville, MD, USA) was used for cloning.
Plasmids and yeast strains are summarized in Table 1. E. coll was grown in LB-medium (Sambrook et al., 1989) with 100mg/I ampidiilin. Liquid cultures of S. cerevisiae defined mineral medium (Verduyn et al., 1990), supplemented with glucose, xylose or arabinose as carbon source and in necessary, buffered with phthalate (10.21 g/l phthalate, 2.1 g/!
KOH, pH 5.5) before sterilization. For plate cultures YPD-agar or SC-plates (6.7 g/l Difco
Yeast Nitrogen Base, 30 g/I agar) were used. Geneticin was added to YPD plates at 200 mg/l.
Molecular biology techniques
Standard molecular biology techniques were used (Sambrook et al., 1989). The lithium acetate method was used for yeast transformation (Gletz et al., 1995).
RESULTS
"Plasmid and strain construction for industrial strain background
A single-copy integrative vector carrying a mutant L-ribulokinase from E. coi (Becker and
Boles, 2003 Appl Environ Microbiol 69, 4144-50) was constructed for attaining a low-level expression of the gene. The KanMX antibiotic marker flanked by lox-sequences was amplified from pUG6 (Guldener et al. 1996) with primers containing the Apal restriction site, and the resulting fragment digested with Apal was cloned to plasmid YEparaB (Becker and Boles, 2003 Appl Environ Microblol 69, 4144-50), also cut with Apal. The resulting plasmid was cut with SnaBI and Eco 311 to destroy the 2p-sequence of the plasmid. The resulting plasmid YIpAraB (Figure 1.) The resulting plasmid pAraBint (Figure 1.) was digested with Eco811I located in the Trp1-marker of the plasmid and transformed in S. cerevisiae TMB 3400, resulting In Integration of the plasmid in the Trpi-locus.
Transformants were selected on YPD-plates containing geneticin, and the presence of the
AraB gene was confirmed by PCR. The resulting yeast strain was named TMB 3060.
For making a template for DNA-fragments to be multiply integrated into the genome, plasmid containing two adjacent regions from the S. cerevisiae ribosomal DNA (rDNA) in an ends-in fashion was constructed. Two PCR-products were amplified from S. cerevisiae
CEN.PK 113-5D chromosomal DNA with primers containing restriction sites for Kpnl and
Apal or Sacl and Sacll. The 400 - 500 bp- long PCR products were digested with these restriction enzymes and cloned into pBluescript SK cut with the same enzymes. The resulting plasmid was named prDNA2 (Figure 2).
The genes for AraA (L-arabinose isomerase) and AraD (L-ribulose-5-P 4-epimerase) from
B. subtilis and E. coli, respectively, were cloned into prDNA2. Fragments containing these genes flanked by the truncated HXT7-promoter (Hauf et al. 2000 Enzyme Microb Technol 26, 688-698) and the CYC1-terminator were acquired from plasmids p424H7AraABs and
S p424H7AraD (Becker and Boles, 2003 Appl Environ Microblol 69, 4144-50) by digestion with Eco52I and Apal. These two fragments were separately cloned into prDNA2 digested with the same enzymes, resulting in plasmids prDNAAraA (Figure 3.) and prDNAAraD (Figure 4.), respectively.
For yeast transformation, fragments containing AraA or AraD genes flanked by rDNA sequence from S. cerevisiae were acquired by PCR with primers in the ribosomal DNA sequences flanking the genes. These fragments are transformed simultaneously to TMB 3060 and transformants are selected for growth on arabinose. The resulting strain is named TMB 3061 and the fermentation properties are studied by batch fermentations.
These fragments were transformed simultaneously to TMB 3060 and transformants are selected for growth on arabinose. The resulting strain was named TMB 3061. The growth of TMB 3061 on arabinose was studied In shake-flask cultures with defined mineral medium supplied with 50 g/l L-arabinose and buffered with pthtalate. (Figure 5.) To assure that the strain had not lost its ability to grow on xylose the xylose growth was confirmed in plate cultures on YNB-medium with 20 g/! xylose.
A similar strategy was followed with strain JBY25 (Becker and Boles, 2003) by progressively integrating PCR-amplified arabinose utilization genes/loxP-kanMX-loxP cassettes Into its rDNA locus. For this, an araD/loxP-kanM-loxP cassette containing short flanking homologous rDNA sequences was transformed into strain JBY25 selecting for growth with 2% glucose In the presence of the antibiotic G418. Into this strain plasmids
YEparaA, YEparaB='* and YEpGAL2 (Becker and Boles, 2003) were transformed.
Transformants growing on L-arabinose as the sole carbon source were cured for their plasmids and the kanMX marker. With the same strategy the B. subtilis araA and E. coll araB®S'* genes were progressively integrated into neighboring rDNA sequences, selecting for growth on L-arabinose. This finally resulted in strain BWY25 with araA, araBS*!A and araD genes integrated into the rDNA locus and able to grow on and to ferment arabinose to ethanol. Finally, plasmid YIpXR/XDH/XK (Eliasson et al., 2000) was Integrated Into the
HIS3 locus, resulting in strain BWY26 able to grow on xylose and/or arabinose as the sole carbon source(s), and to ferment both of them to ethanol.
I iff 8s = 3 roe on <<
Es - a hA
E h-) [] ™ ~ isy [ § © § 33 cg 4 5
ZR = £8 a 2 F =z 8 ® Ss a8 4 w [=a J © Fd ~ a L g 85 EN EEE E 723 £E= ss go g*° "w O09 53g 2? = - o a]
BR 3 lS RS: $5 2 SE Nn a oH
Eg = £2 8 & 9 8 9 [~] [= I~] zi i} = 0 > - 15% 1T 8 8g 3
LR» a3: e ee # rz i° 2 eg 8 =) >
BR ° = 8p § 2 ¢ Iz |g & § ss © 1-3 c H H 8 EE (Ez 3 eX h-) o oc po) oc g 6 h-} [2] [= [sa] §®z is [ § &
ER 3% 4 H H
Ss £8 3 = 2 9 =
TET s © 4&
EE 3 2 «= 3 £3 SB oc : ac eg 35 4 8 H § 3 X ¢ s>¢ | &§& 8 2% 5% " ° £ [=] © a 2 FO 8 JE xg 8 8 c 6 9 E Egg 8 oc =] 8 £ [7] gSgold + H
E L = eel - on
Q 3S o nx = |m o a £3 os E = ° 3
EE 35
Ego 0 - o tn o « 0] 4 Eg 8 3 8
C2 aoa £ ze 9 >] =; P=
GS LQ © u o H +H H 3 9 2. bo) nN $238 ILE gE 8 3
SE > Is & &
Xo a 8 o ww © a oe 5 2 & £ g 3 8
ES 8S Nn o ©o []
Ess 8 E E 8
Ug} £ sd a IEE 5% 8
Combined approach with multicopy and integrative plasmids
Strain JBY25-4M (Becker and Boles, 2003) was selected for improved arabinose fermentation on a medium with 2% arabinose under oxygen-limited conditions over a period of 17 weeks. For this, cells were grown semi-anaerobically in liquid medium with L- arabinose as the sole carbon source for up to 5 days, and progressively diluted into fresh medium whenever the cells had reached the stationary phase. This finally resulted in strain
BWY1-4M that shows an increased growth rate on arabinose medium, higher biomass yields and improved arabinose fermentation.
The Integrative vector YIpXR/XDH/XK (Eliasson et al., 2000) harbouring P. stipitis XYL1 and XYL2 genes, and S. cerevisiae XKS1 and with HIS3 as selectable marker was linearized with Pst to target Integration into the HIS3 locus in the genome of strain BWY1. The transformants were selected for growth on a medium without histidine and with 2% glucose as carbon source. After replica plating the transformants were shown to be able to grow on a synthetic medium with 2% xylose as the sole carbon source.
The araA gene from B. subtilis together with the HX77 promoter and the CYC1 terminator was recloned from plasmid YEparaA (Becker and Boles, 2003) onto plasmid p426H7 with
URA3 as the selectable marker, resulting in plasmid YEparaA (URA3). Plasmids YEparaA (URA3), YEparaB®5!*, YEparaD (Becker and Boles, 2003) were transformed Into strain
BWY1 with YIpXR/XDH/XK Integrated into Its genome, selecting for growth on synthetic minimal medium with 2% glucose. After replica plating the transformants were able to grow on media with xylose and/or arabinose as the sole carbon source(s), and to produce ethanol from both of them.
Figure 6 shows the optical density obtained when fermenting a modified TMB 3061 strain comprising one or more copies of araA and/or araD. The strain was fermented in a 50 ml medium containing xx /I of xylose and 50 g/! of arabinose. The OD was determined at 620 nm and reflects the formation of ethanol during simultaneous consumption of arabinose and xylose.
TMB 3063
To further improve arabinose utilization, TMB 3061 was re-transformed with the AraA gene. Transformants with improved arabinose growth were selected In liquid YNB medium containing 20 g/l arabinose. After three rounds of sequential transfer to new liquid cultures, aliquots were plated on arabinose plates and single colonies were purified and analysed for arabinose growth. The best clone was named TMB 3063. The improved strain
TMB 3063 grew on 50 g/! arabinose with the growth rate of 0.04 h™ and the growth continued until ODg,g of about 6 (Figure 7).
Claims (1)
1. S. cerevisiae strain expressing both arabinose and xylose utilization pathways.
2. S. cerevisiae strain fermenting both arabinose and xylose to ethanol.
3. S. cerevisiae strain with overexpression or upregulation of xylose- or aldose reductase (XR, AR) with xylitol dehydrogenase (XDH) together with overexpression or upregulation of genes forming an arabinose utilization pathway.
4. S. cerevisiae strain with overexpression or upregulation of xylose isomerase (XI) together with overexpression or upregulation of genes forming an arabinose utilization pathway.
5. S. cerevisiae strain comprising an arabinose utilization pathway consisting of AraA corresponding to Bacillus subtills L-arabinose Isomerase, AraB corresponding to Escherichia coll L-ribulokinase, AraD corresponding to E. coll L-ribulose-5-P4- epimerase. ‘
8. S. cerevisiae strain with overexpression or upregulation of genes of the pentose phosphate pathway, TKL and/or TAL and/or RKI and/or RPE.
7. S. cerevisiae strain comprising the genes AraA derived from B. subtilis, AraB derived from E. coli, AraD derived from E. coll, together with the xylose utilization pathway consisting of xylose reductase (XR) and xylitol dehydrogenase (XDH) from Pichia stipitis and endogenous xylulokinase (XKS) of a S. cerevisiae laboratory strain CEN.PK.
8. S. cerevisiae strain comprising the genes AraA derived from B. subtilis, AraB derived from E. coli, AraD derived from E. coll, together with the xylose utilization pathway consisting of heterologous xylose isomerase (XI) genes for isomerisation of xylose to xylulose comprising the XI genes from the thermophilic bacterium Thermus thermophilus and/or from the fungus Piromyces spp.
9. S. cerevisiae strain BWY2 according to one or more of claims 1-8, deposited on the 10 of February 2005 under deposition number DSM 17120 at the Deutsche Sammlung von Mikroorganismen und Zelikulturen GmbH (DSMZ).
10. S. cerevisiae industrial strain TMB 3061 according to one or more of claims 1-8, deposited on the 6 of April, 2005 under the deposition number 17238 at the Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH (DSMZ).
11. S. cerevisiae industrial strain TMB 3061 according to one or more of claims 1-10 comprising one or more copies of the genes araA and/or araD.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0500577 | 2005-03-11 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA200705935B true ZA200705935B (en) | 2008-07-30 |
Family
ID=40677300
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA200705935A ZA200705935B (en) | 2005-03-11 | 2007-07-17 | Arabinose- and xylose-fermenting saccharomyces cerevisiae strains |
Country Status (1)
| Country | Link |
|---|---|
| ZA (1) | ZA200705935B (en) |
-
2007
- 2007-07-17 ZA ZA200705935A patent/ZA200705935B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US8129171B2 (en) | Arabinose- and xylose-fermenting Saccharomyces cerevisiae strains | |
| Ho et al. | Successful design and development of genetically engineered Saccharomyces yeasts for effective cofermentation of glucose and xylose from cellulosic biomass to fuel ethanol | |
| US20060216804A1 (en) | Construction of new xylose utilizing saccharomyces cerevisiae strain | |
| EP2066784B1 (en) | Xylitol synthesis mutant of xylose-utilizing zymomonas for ethanol production | |
| AU2011334846B2 (en) | Method for preparing an industrial yeast, industrial yeast and use in the production of ethanol from at least one pentose | |
| WO1995028476A1 (en) | Recombinant zymomonas for pentose fermentation | |
| ZA200408440B (en) | A modified yeast consuming l-arabinose | |
| Eiteman et al. | A substrate‐selective co‐fermentation strategy with Escherichia coli produces lactate by simultaneously consuming xylose and glucose | |
| US9862975B2 (en) | Compositions and methods for increased ethanol production from biomass | |
| CN105073990A (en) | Production method for ethanol using recombined yeast | |
| CA2327172A1 (en) | Recombinant zymomonas mobilis with improved xylose utilization | |
| Wang et al. | Establishment of a xylose metabolic pathway in an industrial strain of Saccharomyces cerevisiae | |
| Li et al. | Functional expression of xylose isomerase in flocculating industrial Saccharomyces cerevisiae strain for bioethanol production | |
| US20070141690A1 (en) | Mutant saccharomyces cerevisiae strain utilizing xylose for ethanol production | |
| US7374939B1 (en) | Method of inactivation of an end product of energy metabolism in Zymomonas mobilis | |
| ZA200705935B (en) | Arabinose- and xylose-fermenting saccharomyces cerevisiae strains | |
| CA2885934C (en) | Compositions and methods for increased ethanol titer from biomass | |
| US20230183721A1 (en) | Method of modifying a yeast strain, modified yeast strains obtained thereby and uses thereof | |
| JP4528972B2 (en) | Chromosomally integrated mannose-fermenting Zymomonas bacterium | |
| Zhang et al. | Optimized xylose isomerase uptake and expression level in Saccharomyces cerevisiae for | |
| TWI526536B (en) | Recombinant yeast cell, and the preparation process and uses thereof |